A recombinant single-chain antibody interleukin-2 fusion protein
- 53 Downloads
Recombinant interleukin-2 (rIL-2) therapy has been shown to be of value in the treatment of some cases of melanoma and renal cell carcinoma. However, its use can be limited by severe systemic toxicity. Targeting rIL-2 to the tumor should improve the antitumor immune response and decrease the systemic toxicity. With this aim, we have employed recombinant DNA techniques to construct a single-chain antibody interleukin-2 fusion protein (SCA-IL-2).
The protein used in this model system consists of the variable domains of the antilysozyme antibody D1.3 fused to human IL-2 and is expressed inE. coli. It retains antigen-binding specificity and has the full biological activity of rIL-2.
This approach can be taken to generate SCA-IL-2 proteins that bind to appropriate cellular antigens. In vivo administration of tumor-binding SCA-IL-2 should result in a localized high concentration of rIL-2 in the tumor tissues, maximizing the antitumor response while keeping systemic side effects to a minimum.
Index EntriesBacterial expression single chain antibody fusion protein interleukin-2
single-chain antibody interleukin-2 fusion protein
Unable to display preview. Download preview PDF.
- 4.Williams, D. P., Parker, K., Bacha, P., Bishai, W., Borowski, M., Gebauffe, F., Strom, T. B., and Murphy, J. R. (1987) Diptheria toxin receptor binding domain substitution with interleukin-2: genetic construction and properties of a diptheria toxin-related interleukin-2 fusion protein.Prot. Engin. 1, 493–498.CrossRefGoogle Scholar
- 7.Landolf, N. F. (1991) A chimeric IL-2/Ig molecule possesses the functional activity of both proteins.J. Immunol. 146, 915–919.Google Scholar
- 9.Houston, J. S., Levinson D., Mudgett-Hunter, M., Tai, M.-S., Novotny, J., Margolies, M. N., Ridge, R. J., Bruccoleri, R. E., Haber, E., Crea, R., and Opperman, H. (1988) Protein engineering of antibody binding sites: recovery of specific activity in an anti-digoxin single-chain Fv anlogue produced inEscherichia coli.Proc. Natl. Acad. Sci. USA 85, 5879–5883.CrossRefGoogle Scholar
- 14.Stauch, K. L., Johnson, K., and Beckwith, J. (1989) Characterization of degP; a gene required for proteolysis in the cell envelope and essential for growth ofEscherichia coli at high temperature,J. Bact. 171, 2689–2696.Google Scholar
- 21.Savage, P. M., Beynon, H. C., Hartourian, R., Walport, M. J., and Epenetos, A. A. (1992) A single chain antibody interleukin-2 fusion protein mimics the effects of rIL-2 on endothelial cell permeability, inCell Adhesion Molecules in Cancer and Inflammation (Epenetos, A. A., ed.), Chapman and Hall, London.Google Scholar